UniProt ID | PIPNA_HUMAN | |
---|---|---|
UniProt AC | Q00169 | |
Protein Name | Phosphatidylinositol transfer protein alpha isoform | |
Gene Name | PITPNA | |
Organism | Homo sapiens (Human). | |
Sequence Length | 270 | |
Subcellular Localization | Cytoplasm. | |
Protein Description | Catalyzes the transfer of PtdIns and phosphatidylcholine between membranes.. | |
Protein Sequence | MVLLKEYRVILPVSVDEYQVGQLYSVAEASKNETGGGEGVEVLVNEPYEKDGEKGQYTHKIYHLQSKVPTFVRMLAPEGALNIHEKAWNAYPYCRTVITNEYMKEDFLIKIETWHKPDLGTQENVHKLEPEAWKHVEAVYIDIADRSQVLSKDYKAEEDPAKFKSIKTGRGPLGPNWKQELVNQKDCPYMCAYKLVTVKFKWWGLQNKVENFIHKQERRLFTNFHRQLFCWLDKWVDLTMDDIRRMEEETKRQLDEMRQKDPVKGMTADD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Sumoylation | ---MVLLKEYRVILP ---CCEEEEEEEEEE | 48.84 | - | |
5 | Ubiquitination | ---MVLLKEYRVILP ---CCEEEEEEEEEE | 48.84 | - | |
5 | Sumoylation | ---MVLLKEYRVILP ---CCEEEEEEEEEE | 48.84 | - | |
7 | Phosphorylation | -MVLLKEYRVILPVS -CCEEEEEEEEEEEE | 14.48 | 24043423 | |
14 | Phosphorylation | YRVILPVSVDEYQVG EEEEEEEECCEEEHH | 23.16 | 22817901 | |
18 | Phosphorylation | LPVSVDEYQVGQLYS EEEECCEEEHHHEEE | 12.20 | 24043423 | |
24 | Phosphorylation | EYQVGQLYSVAEASK EEEHHHEEEHHHHHC | 8.00 | 24043423 | |
25 | Phosphorylation | YQVGQLYSVAEASKN EEHHHEEEHHHHHCC | 24.36 | 24043423 | |
30 | Phosphorylation | LYSVAEASKNETGGG EEEHHHHHCCCCCCC | 27.76 | 24043423 | |
50 | Acetylation | LVNEPYEKDGEKGQY EECCCCCCCCCCCCC | 66.25 | 66693765 | |
50 | Ubiquitination | LVNEPYEKDGEKGQY EECCCCCCCCCCCCC | 66.25 | 21906983 | |
54 | Ubiquitination | PYEKDGEKGQYTHKI CCCCCCCCCCCEEHH | 57.77 | - | |
57 | Phosphorylation | KDGEKGQYTHKIYHL CCCCCCCCEEHHEEH | 21.34 | 18083107 | |
58 | Phosphorylation | DGEKGQYTHKIYHLQ CCCCCCCEEHHEEHH | 14.59 | 15322105 | |
60 | Ubiquitination | EKGQYTHKIYHLQSK CCCCCEEHHEEHHHC | 36.84 | - | |
62 | Phosphorylation | GQYTHKIYHLQSKVP CCCEEHHEEHHHCCC | 10.98 | 29496907 | |
67 | Ubiquitination | KIYHLQSKVPTFVRM HHEEHHHCCCCHHHH | 38.99 | - | |
74 | Sulfoxidation | KVPTFVRMLAPEGAL CCCCHHHHHCCCCCC | 2.92 | 21406390 | |
86 | Ubiquitination | GALNIHEKAWNAYPY CCCCHHHHHHHHCCC | 44.53 | 21890473 | |
91 | Phosphorylation | HEKAWNAYPYCRTVI HHHHHHHCCCCCEEE | 7.48 | 28152594 | |
93 | Phosphorylation | KAWNAYPYCRTVITN HHHHHCCCCCEEECC | 5.06 | 20090780 | |
110 | Ubiquitination | MKEDFLIKIETWHKP HHHCEEEEEEECCCC | 36.32 | - | |
127 | Ubiquitination | GTQENVHKLEPEAWK CCCCCHHHCCHHHHH | 50.71 | - | |
134 | Acetylation | KLEPEAWKHVEAVYI HCCHHHHHCCEEEEE | 44.83 | 27452117 | |
140 | Phosphorylation | WKHVEAVYIDIADRS HHCCEEEEEECHHHH | 10.42 | 24927040 | |
146 | Methylation | VYIDIADRSQVLSKD EEEECHHHHHHHCCC | 21.70 | 115487595 | |
147 | Phosphorylation | YIDIADRSQVLSKDY EEECHHHHHHHCCCC | 25.78 | 27282143 | |
152 | Ubiquitination | DRSQVLSKDYKAEED HHHHHHCCCCCCCCC | 62.00 | 21890473 | |
162 | Acetylation | KAEEDPAKFKSIKTG CCCCCHHHCCCCCCC | 59.73 | 25953088 | |
162 | Ubiquitination | KAEEDPAKFKSIKTG CCCCCHHHCCCCCCC | 59.73 | 21890473 | |
165 | Phosphorylation | EDPAKFKSIKTGRGP CCHHHCCCCCCCCCC | 32.24 | 15322105 | |
178 | Ubiquitination | GPLGPNWKQELVNQK CCCCCCHHHHHHCCC | 40.30 | 21890473 | |
185 | Ubiquitination | KQELVNQKDCPYMCA HHHHHCCCCCCCEEE | 56.97 | - | |
199 | Acetylation | AYKLVTVKFKWWGLQ EEEEEEEEHHHHHCH | 31.68 | 25953088 | |
201 | Ubiquitination | KLVTVKFKWWGLQNK EEEEEEHHHHHCHHH | 36.00 | 21890473 | |
201 | Acetylation | KLVTVKFKWWGLQNK EEEEEEHHHHHCHHH | 36.00 | 25953088 | |
208 | Ubiquitination | KWWGLQNKVENFIHK HHHHCHHHHHHHHHH | 37.66 | 21890473 | |
215 | Ubiquitination | KVENFIHKQERRLFT HHHHHHHHHHHHHHH | 49.38 | 19608861 | |
215 | Acetylation | KVENFIHKQERRLFT HHHHHHHHHHHHHHH | 49.38 | 19608861 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PIPNA_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PIPNA_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
PMVK_HUMAN | PMVK | physical | 17353931 | |
MO4L2_HUMAN | MORF4L2 | physical | 17353931 | |
MLKL_HUMAN | MLKL | physical | 17353931 | |
NLTP_HUMAN | SCP2 | physical | 15182174 | |
UB2L3_HUMAN | UBE2L3 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-215, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-57, AND MASSSPECTROMETRY. |